These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3383933)

  • 21. The effects of calcium channel blocking drugs on halothane initiation of malignant hyperthermia in MHS swine and on the established syndrome.
    Harrison GG; Wright IG; Morrell DF
    Anaesth Intensive Care; 1988 May; 16(2):197-201. PubMed ID: 3394913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Failure of verapamil to protect from ischaemic renal damage.
    Bock HA; Brunner FP; Torhorst J; Thiel G
    Nephron; 1991; 57(3):299-305. PubMed ID: 2017270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease.
    Packer M; Medina N; Yushak M
    J Am Coll Cardiol; 1984 Nov; 4(5):890-901. PubMed ID: 6491082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitussive effects of Ca2+ channel antagonists.
    Kamei J; Kasuya Y
    Eur J Pharmacol; 1992 Feb; 212(1):61-6. PubMed ID: 1555640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of protection of verapamil by preventing neutrophil infiltration in the ischemic rat kidney.
    López-Neblina F; Páez-Rollys AJ; Toledo-Pereyra LH
    J Surg Res; 1996 Mar; 61(2):469-72. PubMed ID: 8656627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. L-arginine reduces tubular cell injury in acute post-ischaemic renal failure.
    Jerkić M; Varagić J; Jovović D; Radujković-Kuburović G; Nastić-Mirić D; Adanja-Grujić G; Marković-Lipkovski J; Dimitrijević J; Miloradović Z; Vojvodić SB
    Nephrol Dial Transplant; 1999 Jun; 14(6):1398-407. PubMed ID: 10382999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ischaemic conditioning reduces kidney injury in an experimental large-animal model of warm renal ischaemia.
    Hunter JP; Hosgood SA; Barlow AD; Nicholson ML
    Br J Surg; 2015 Nov; 102(12):1517-25. PubMed ID: 26263908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on calcium-channel blocking agents.
    Talbert RL; Bussey HI
    Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preservation of myocardial blood flow by calcium antagonists does not prevent attenuation of regional myocardial function after repetitive brief periods of myocardial ischaemia in the rat heart.
    Tiefenbacher CP; Zimmermann R; Parekh N; Amann K; Tillmanns H; Rauch B; Kübler W
    Eur Heart J; 1995 Aug; 16(8):1057-62. PubMed ID: 8665966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination therapy with beta-adrenoceptor blockers and calcium antagonists.
    Dargie HJ
    Br J Clin Pharmacol; 1986; 21 Suppl 2(Suppl 2):155S-160S. PubMed ID: 2875727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Possible protective role of calcium inhibitors in drug nephrotoxicity].
    Deray G; Dubois M; Martinez F; Baumelou A; Jacobs C
    Therapie; 1989; 44(3):183-7. PubMed ID: 2675380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium channel blockade in experimental aminoglycoside nephrotoxicity.
    Watson AJ; Gimenez LF; Klassen DK; Stout RL; Whelton A
    J Clin Pharmacol; 1987 Aug; 27(8):625-7. PubMed ID: 3655010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium antagonists as radiation modifiers: site specificity in relation to tumor response.
    Wood PJ; Hirst DG
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1141-4. PubMed ID: 2715060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium antagonists for Duchenne muscular dystrophy.
    Phillips MF; Quinlivan R
    Cochrane Database Syst Rev; 2008 Oct; (4):CD004571. PubMed ID: 18843663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effect of a novel calcium blocker, S-312-d, on ischemic acute renal failure in rat.
    Shimizu T; Kawabata T; Nakamura M
    J Pharmacol Exp Ther; 1990 Nov; 255(2):484-90. PubMed ID: 2243338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective action of calcium entry blockers in endotoxin shock.
    Lee HC; Lum BK
    Circ Shock; 1986; 18(3):193-203. PubMed ID: 2938842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker.
    Bui-Xuan B; Aupetit JF; Freysz M; Loufoua-Moundanga J; Faucon G; Timour Q
    Arch Int Pharmacodyn Ther; 1996; 331(3):246-62. PubMed ID: 9124997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive rats.
    Vaja V; Ochodnicky P; Krenek P; Klimas J; Bajuszova Z; Kyselovic J
    Eur J Pharmacol; 2009 Oct; 619(1-3):85-91. PubMed ID: 19683522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of ischemic-induced damage to cerebral adenylate cyclase in gerbils by calcium channel blockers.
    Christie-Pope BC; Palmer GC
    Metab Brain Dis; 1986 Dec; 1(4):249-61. PubMed ID: 3508245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mechanisms of the protective action of the calcium antagonists corynphar and verapamil in myocardial ischemia and subsequent reperfusion].
    Litvitskiĭ PF
    Farmakol Toksikol; 1982; 45(2):65-70. PubMed ID: 7075755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.